In the published article, there was an error in the Funding statement. We failed inadvertently to acknowledge one of our funding bodies in the “Funding” section. The Funding statement read as “This work was supported by a grant from Stavros Niarchos Foundation (ST and MZ), by RSF (Grant No. 16-14-00215) (VT and II), by RFBR (Grant No. 18-04-01366) (IK) and by BioStruct-X (Contract No. 283570/3521).”
The correct statement is: “This work was supported by a grant from Stavros Niarchos Foundation (ST and MZ), by RSF (Grant No. 16-14-00215) (VT and II), by RFBR (Grant No. 18-04-01366) (IK), by the Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Technology (PG), (StruNic, Grant No. 677) and by BioStruct-X (Contract No. 283570/3521).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
nicotinic acetylcholine receptors, α-conotoxins, RgIA, structure, molecular modeling, molecular dynamics
Citation
Zouridakis M, Papakyriakou A, Ivanov IA, Kasheverov IE, Tsetlin V, Tzartos S and Giastas P (2022) Corrigendum: Crystal structure of the monomeric extracellular domain of α9 nicotinic receptor subunit in complex with α-conotoxin RgIA: Molecular dynamics insights into RgIA binding to α9α10 nicotinic receptors. Front. Pharmacol. 13:980202. doi: 10.3389/fphar.2022.980202
Received
28 June 2022
Accepted
28 July 2022
Published
25 August 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Zouridakis, Papakyriakou, Ivanov, Kasheverov, Tsetlin, Tzartos and Giastas.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Marios Zouridakis, marzouri@gmail.com; Petros Giastas, petrosgiastas@gmail.com
This article was submitted to Pharmacology of Ion Channels and Channelopathies, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.